Studies have shown that the synovial inflammation of RA is associated with the release of inflammatory factors such as matrix metalloproteinases, tumor necrosis factor α and interleukin-6 after the activation of IL-17, TNF, TLRs, MAPKs, NF-κB and other pathways6. The gene discussed is IL17A; the disease is rheumatoid arthritis.